New Opioid Data May Not Reflect Harms Accurately, FDA Advisors Warn

(MedPage Today) -- New research about the harms of long-acting opioids may underestimate risks, members of two FDA advisory committees said Monday.
Data did not represent large segments of the U.S. population and relied on varying definitions...